Endocrinology, Vol 129, 2266-2268, Copyright © 1991 by Endocrine Society

ARTICLES

The ovarian expression of the antigonadotropic insulin-like growth factor binding protein-2 is theca-interstitial cell-selective: evidence for hormonal regulation

E Ricciarelli, ER Hernandez, A Hurwitz, E Kokia, RG Rosenfeld, J Schwander and EY Adashi
Department of Obstetrics/Gynecology, University of Maryland School of Medicine, Baltimore 21201.

To begin the process of identification and charactization of rat ovarian insulin-like growth factor binding proteins, we have undertaken to explore the ovarian expression, cellular localization, and hormonal regulation of the insulin-like growth factor binding protein-2 (IGFBP- 2) gene for which an antigonadotropic potential has recently been demonstrated. To this end, a solution hybridization/RNase protection assay was employed wherein total ovarian RNA (20 micrograms) from immature (21-23 days old) female rats was hybridized with a [32P]- labeled IGFBP-2 riboprobe. As in liver, a single protected fragment (550 bases long) corresponding to IGFBP-2 transcripts was identified in whole ovarian material. Cellular localization studies revealed the IGFBP-2 gene to be exclusively expressed in the theca-interstitial rather than the granulosa cell compartment. To confirm the cellular distribution of the IGFBP-2 protein, media conditioned by cultured granulosa or theca-interstitial cells were subjected to immunoprecipitation using two IGFBP-2-directed polyclonal antisera. Expectedly, both antibodies (but not non-immune rabbit serum) readily immunoprecipitated the 28 kDa rat IGFBP-2 species generated by hepatic BRL-3A cells. Similarly, both antibodies effectively immunoprecipitated an IGFBP the size of rat IGFBP-2 elaborated by theca-interstitial cells. In contrast, neither antibody immunoprecipitated the 28-29 kDa IGFBP species elaborated by granulosa cells otherwise readily apparent in conventional Western ligand blots. Hypophysectomy resulted in a 3- fold decrease (P less than 0.05) in the relative (densitometrically- quantified) abundance of ovarian IGFBP-2 transcripts, a diametrically opposed effect (P less than 0.05) being noted at the level of the liver. In contrast, treatment of immature hypophysectomized rats with a diethylstilbestrol-containing subcutaneous silastic implant for a total of 5 days resulted in a concordant 3-fold increase (P less than 0.05) in the relative abundance of IGFBP-2 transcripts in both ovary and liver when compared with untreated hypophysectomized controls. Taken together, these findings document rat ovarian IGFPB-2 gene expression to be theca-interstitial (rather than granulosa) cell-selective, and subject to upregulatory control by pituitary principle(s) and/or by estrogens. Although equally estrogen-dependent, hepatic IGFBP-2 gene expression proved constitutive in nature and subject to (diametrically opposed) inhibitory control by (potentially distinct) pituitary principle(s).

This article has been cited by other articles:

				T. R. Davidson, C. S. Chamberlain, T. S. Bridges, and L. J. Spicer Effect of Follicle Size on In Vitro Production of Steroids and Insulin-Like Growth Factor (IGF)-I, IGF-II, and the IGF-Binding Proteins by Equine Ovarian Granulosa Cells Biol Reprod, June 1, 2002; 66(6): 1640 - 1648. [Abstract] [Full Text] [PDF]

				C. Aguirre, F. C. L. Jayes, and J. D. Veldhuis Luteinizing Hormone (LH) Drives Diverse Intracellular Calcium Second Messenger Signals in Isolated Porcine Ovarian Thecal Cells: Preferential Recruitment of Intracellular Ca2+ Oscillatory Cells by Higher Concentrations of LH Endocrinology, June 1, 2000; 141(6): 2220 - 2228. [Abstract] [Full Text] [PDF]

				L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF]

				M. Ando, S. Kol, E. Kokia, K. Ruutiainen-Altman, J. Sirois, R. M. Rohan, D. W. Payne, and E. Y. Adashi Rat Ovarian Prostaglandin Endoperoxide Synthase-1 and -2: Periovulatory Expression of Granulosa Cell-Based Interleukin-1-Dependent Enzymes Endocrinology, May 1, 1998; 139(5): 2501 - 2508. [Abstract] [Full Text] [PDF]

				E. Y. Adashi, C. E. Resnick, D. W. Payne, R. G. Rosenfeld, T. Matsumoto, M. K. Hunter, S. E. Gargosky, J. Zhou, and C. A. Bondy The Mouse Intraovarian Insulin-Like Growth Factor I System: Departures from the Rat Paradigm Endocrinology, September 1, 1997; 138(9): 3881 - 3890. [Abstract] [Full Text] [PDF]

				L. Putowski, R. M. Rohan, D. S. Choi, W. J. Scherzer, E. Ricciarelli, J. Mordacq, K. E. Mayo, and E. Y. Adashi Rat Ovarian Insulin-Like Growth Factor Binding Protein-4: A Hormone-Dependent Granulosa Cell-Derived Antigonadotropin Reproductive Sciences, May 1, 1997; 4(3): 144 - 151. [Abstract] [PDF]

				E. Y. Adashi Insulin-Like Growth Factors as Determinants of Follicular Fate Reproductive Sciences, November 1, 1995; 2(6): 721 - 726. [Abstract] [PDF]

				L. T. Putowski, D. Choi, J. Mordacq, W. J. Scherzer, K. E. Mayo, E. Y. Adashi, and R. M. Rohan In vivo Hormonal Regulation of Insulin-Like Growth Factor Binding Protein-5 mRNA in the Immature Rat Ovary Reproductive Sciences, November 1, 1995; 2(6): 735 - 742. [Abstract] [PDF]